Evidence map›Paper›PMID 36363994›Full record

ReviewMolecules (Basel, Switzerland)2022

The Role of Astaxanthin as a Nutraceutical in Health and Age-Related Conditions.

Geir Bjørklund, Amin Gasmi, Larysa Lenchyk, Mariia Shanaida, Saba Zafar, Pavan Kumar Mujawdiya, Roman Lysiuk, Halyna Antonyak, Sadaf Noor, Muhammad Akram and 4 more

Registry-linked trialAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06642363 (The Effectiveness of Astaxanthin Supplementation on the Clinical Symptoms and Cardio-metabolic Profile in Women with Polycystic Ovary Syndrome), which is not on this map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06642363 phase1recruitingnot on this mapstarted 2024, after this paper: background citation

The Effectiveness of Astaxanthin Supplementation on the Clinical Symptoms and Cardio-metabolic Profile in Women with Polycystic Ovary Syndrome: a Protocol for a Randomized Double-blinded, Placebo-controlled Parallel-group Study

TypeinterventionalSponsorIsfahan University of Medical SciencesRan2024 to 2025Enrolled44ConditionsPCO - Polycystic Ovaries, Obesity and Obesity-related Medical ConditionsArmsSubjects in the intervention group will receive one capsule containing 10 mg Astaper day made by the "Zyest Technology Tarawat Zendig" institute in Iran. The dosage of ASX is determined based on the s, Placebo
3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Astaxanthin fromMarine drugs · 2025
    Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. EngineeredLife (Basel, Switzerland) · 2025
    Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Geir BjørklundCouncil for Nutritional and Environmental Medicine (CONEM), Toften 24, 8610 Mo i Rana, Norway.ORCID 0000-0003-2632-3935
Amin GasmiSociété Francophone de Nutrithérapie et de Nutrigénétique Appliquée, 69100 Villeurbanne, France.ORCID 0000-0003-2165-8373
Larysa LenchykInstitute for Advanced Training of Pharmacy Specialist, National University of Pharmacy, 61001 Kharkiv, Ukraine.
Mariia ShanaidaDepartment of Pharmacognosy and Medical Botany, I. Horbachevsky Ternopil National Medical University, 46001 Ternopil, Ukraine.ORCID 0000-0003-1070-6739
Saba ZafarDepartment of Biochemistry and Biotechnology, The Women University, Multan 60000, Pakistan.
Pavan Kumar MujawdiyaInochi Care Private Limited, Main Market, Malviya Nagar, New Delhi 110017, India.
Roman LysiukDepartment of Pharmacognosy and Botany, Danylo Halytsky Lviv National Medical University, 79010 Lviv, Ukraine.ORCID 0000-0003-0961-2970
Halyna AntonyakDepartment of Ecology, Ivan Franko National University of Lviv, 79005 Lviv, Ukraine.ORCID 0000-0002-1640-737X
Sadaf NoorInstitute of Molecular Biology and Biotechnology, Bahauddin Zakariya University, Multan 60800, Pakistan.
Muhammad AkramMedicine, Government College University, Faisalabad 38000, Pakistan.ORCID 0000-0002-7457-8572
Kateryna SmetaninaDepartment of Organic Chemistry and Pharmacy, Lesya Ukrainka Volyn National University, 43025 Lutsk, Ukraine.ORCID 0000-0003-0040-2096
Salva PiscopoSociété Francophone de Nutrithérapie et de Nutrigénétique Appliquée, 69100 Villeurbanne, France.
Taras UpyrCONEM Ukraine Pharmacognosy and Natural Product Chemistry Research Group, National University of Pharmacy, 61002 Kharkiv, Ukraine.ORCID 0000-0003-2374-5497
Massimiliano PeanaDepartment of Chemical, Physical, Mathematical and Natural Sciences, University of Sassari, 07100 Sassari, Italy.ORCID 0000-0002-3306-0419

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current review provides an up-to-date analysis of scientific data on astaxanthin (ASX) sources and experimental studies on its health benefits as a potent antioxidant in the aging process. ASX is a liposoluble carotenoid nutrient and reddish-orange pigment, naturally synthesized by numerous microalgae, yeasts, and bacteria as secondary metabolites. Provides a reddish hue to redfish and shellfish flesh that feed on ASX-producing microorganisms. The microalga

Indexed as

AntioxidantsXanthophyllsbeta CaroteneDietary SupplementsAntioxidantsastaxanthinebeta CaroteneXanthophyllsantioxidant supplementationastaxanthincarotenoidhealth benefithuman agingneuroprotectionreactive oxygen speciesskin protection

Identifiers

PMID36363994
PMCPMC9655540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.